kynurenic acid has been researched along with Astrocytosis in 5 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
Excerpt | Relevance | Reference |
---|---|---|
"Curcumin may enhance the inflammation-induced IDO/KYN axis and allosterically regulate endogenous ligand binding to AhR, facilitating AhR activation to regulate inflammatory astrogliosis." | 1.72 | Curcumin Facilitates Aryl Hydrocarbon Receptor Activation to Ameliorate Inflammatory Astrogliosis. ( Chou, CC; Hung, CC; Lee, YH; Lin, CH, 2022) |
"Neuronal loss and gliosis in these animals were examined immunohistochemically." | 1.33 | Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats. ( Bertram, EH; Goodman, JH; Rassoulpour, A; Scharfman, HE; Schwarcz, R; Wu, HQ, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Lin, CH | 1 |
Chou, CC | 1 |
Lee, YH | 1 |
Hung, CC | 1 |
Majerova, P | 1 |
Olesova, D | 1 |
Golisova, G | 1 |
Buralova, M | 1 |
Michalicova, A | 1 |
Vegh, J | 1 |
Piestansky, J | 1 |
Bhide, M | 1 |
Hanes, J | 1 |
Kovac, A | 1 |
Wu, HQ | 1 |
Rassoulpour, A | 1 |
Goodman, JH | 1 |
Scharfman, HE | 1 |
Bertram, EH | 1 |
Schwarcz, R | 1 |
Rejdak, K | 1 |
Petzold, A | 1 |
Kocki, T | 1 |
Kurzepa, J | 1 |
Grieb, P | 1 |
Turski, WA | 1 |
Stelmasiak, Z | 1 |
Suma, T | 1 |
Koshinaga, M | 1 |
Fukushima, M | 1 |
Kano, T | 1 |
Katayama, Y | 1 |
5 other studies available for kynurenic acid and Astrocytosis
Article | Year |
---|---|
Curcumin Facilitates Aryl Hydrocarbon Receptor Activation to Ameliorate Inflammatory Astrogliosis.
Topics: Animals; Curcumin; Gliosis; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interleukin-6; Kynurenic Acid; Kyn | 2022 |
Analog of kynurenic acid decreases tau pathology by modulating astrogliosis in rat model for tauopathy.
Topics: Animals; Gliosis; Kynurenic Acid; Kynurenine; Neurodegenerative Diseases; Neuroprotective Agents; Ra | 2022 |
Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats.
Topics: Animals; Astrocytes; Disease Models, Animal; Entorhinal Cortex; Epilepsy; Epilepsy, Temporal Lobe; E | 2005 |
Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis.
Topics: Acute Disease; Adult; Astrocytes; Biomarkers; Brain; Encephalitis; Female; Gliosis; Humans; Kynureni | 2007 |
Effects of in situ administration of excitatory amino acid antagonists on rapid microglial and astroglial reactions in rat hippocampus following traumatic brain injury.
Topics: Animals; Astrocytes; Brain Injuries; CD11b Antigen; Disease Models, Animal; Excitatory Amino Acid An | 2008 |